From: Barriers to successful care for chronic kidney disease
 | All (N = 198) | LNC†(N = 146) | SNC†(N = 52) | P-value |
---|---|---|---|---|
Ethnicities | ||||
Hispanic | 46% | 44% | 54% | 0.214 |
African American | 43% | 48% | 31% | 0.032 |
Haitian | 7% | 7% | 8% | 0.839 |
Caucasian | 3% | 1% | 5% | 0.083 |
Asian | 1% | 0% | 2% | 0.093 |
Age [Years] | ||||
Mean ± SD | 56 ± 13.4 | 51 ± 14 | 58 ± 12.7 | 0.001 |
<31 | 4% | 1% | 10% | 0.006 |
31–40 | 10% | 8% | 14% | 0.270 |
41–50 | 20% | 19% | 21% | 0.758 |
51–60 | 25% | 23% | 31% | 0.241 |
61–70 | 28% | 32% | 17% | 0.041 |
71–80 | 12% | 13% | 8% | 0.304 |
>80 | 3% | 3% | 2% | 0.176 |
Gender | ||||
Female | 53% | 55% | 48% | 0.405 |
CKD Stage | ||||
Stage 4 | 47% | 48% | 44% | 0.645 |
Length of Nephrology Care [Months] | ||||
0–1 | 9% | 0% | 35% | - |
2–6 | 17% | 0% | 65% | - |
7–12 | 14% | 20% | 0% | - |
13–24 | 15% | 22% | 0% | - |
24–36 | 15% | 21% | 0% | - |
>36 | 30% | 44% | 0% | - |
Co-Morbidities | ||||
Hypertension | 92% | 95% | 83% | 0.004 |
Hyperlipidemia | 66% | 71% | 52% | 0.015 |
Diabetes | 50% | 45% | 65% | 0.008 |
Estimated GFR at Referral to Nephrology [ml/min/1.73 m 2 ] | ||||
Mean ± SD | 26 ± 14.9 | 29 ± 15.7 | 17 ± 8.3 | <0.001 |
<15 | 21% | 13% | 42% | <0.001 |
15–29 | 52% | 51% | 52% | 0.945 |
30–59 | 24% | 31% | 6% | <0.001 |
>59 | 4% | 5% | 0% | 0.108 |